LEE KENNETH B JR

CIK 000120857012 companiesCHAPEL HILL, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001208570

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-13+16,745→ 68,863 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-01-31$1.71/sh+15,000→ 52,118 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2023-01-31−15,000→ 0 total
Award
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2022-06-16+22,222→ 64,544 total
Award
HYPERION DEFI, INC.$HYPD
Stock Option (right to buy)
2022-06-16+30,769→ 30,769 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-06-07+12,866→ 37,118 total
Purchase
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2022-05-19$2.20/sh+10,000→ 42,322 total
Award
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2021-11-17+6,963→ 32,322 total
Award
HYPERION DEFI, INC.$HYPD
Stock Option (right to buy)
2021-11-17+9,653→ 9,653 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-09-13$3.22/sh+15,000→ 30,252 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-09-13$15.35/sh−6,000→ 24,252 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-09-13−15,000→ 0 total
Purchase
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2021-06-15$5.41/sh+2,000→ 25,359 total
Purchase
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2021-06-14$5.47/sh+2,000→ 23,359 total
Purchase
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2021-06-11$5.38/sh+2,000→ 21,359 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-05-25+40,000→ 40,000 total
Award
HYPERION DEFI, INC.$HYPD
Stock Option (right to buy)
2020-09-11+9,820→ 9,820 total
Award
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2020-09-11+7,288→ 19,359 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2020-05-12+40,000→ 40,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-11-18$1.45/sh+5,000→ 15,252 total
Award
HYPERION DEFI, INC.$HYPD
Stock Option (right to buy)
2019-08-16+9,057→ 9,057 total
Award
HYPERION DEFI, INC.$HYPD
Common Stock, par value $.0001
2019-08-16+8,038→ 12,071 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2019-05-29+30,000→ 30,000 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−226,061→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−458→ 1,044,764 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−1,731→ 0 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+19,061→ 1,045,222 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−4,309→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+12,487→ 163,099 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−41,414→ 0 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+1,731→ 94,916 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+47,458→ 150,459 total
Conversion
PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
2018-10-22−42,530→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+266,481→ 266,481 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+150,612→ 150,612 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−104→ 13,558 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+137,513→ 1,820,933 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−19,061→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−42→ 94,874 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−94,874→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+150,000→ 416,481 total
Conversion
PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
2018-10-22−13,609→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−272,107→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−149,320→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−994→ 40,420 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+52,690→ 52,690 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+1,683,420→ 1,683,420 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+4,846→ 4,846 total

LEE KENNETH B JR

Recent Transactions

Companies

Recent Filings

Address